Insulin is a chemical that the body needs in order to use or store sugar. It is made by a type of cell called a beta cell which resides in an organ known as the pancreas. Type 2 diabetes is a disease where the beta cells are unable to meet a person's insulin needs. Sugar levels rise in the blood as a result. INGAP-Peptide is being tested to attempt to create new beta cells in the pancreas, and to improve the ability to produce insulin in type 2 diabetic patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
126
1.5 mL, once daily, self-administered SC injection for 90 days
1.5 mL, once daily, self-administered SC injection for 90 days
1.5 mL, once daily, self-administered SC injection for 90 days
Diabetes and Endocrine Associates
La Jolla, California, United States
VA Hospital UCSD
San Diego, California, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Diablo Clinical Research
Walnut Creek, California, United States
Unnamed facility
Denver, Colorado, United States
Longmont Medical Research Network
Longmont, Colorado, United States
MedStar Clinical Research Center
Washington D.C., District of Columbia, United States
Future Care Studies
Springfield, Massachusetts, United States
Mercury Street Medical
Butte, Montana, United States
Diabetes-Endocrinology Center of WNY
Buffalo, New York, United States
UNC Diabetes Care Center
Durham, North Carolina, United States
...and 7 more locations